百令胶囊联合依帕司他治疗早期糖尿病肾病的临床观察被引量：11

Clinical Effect of Bailing Capsules Combined with Epalrestat Capsules in the Treatment of Early Diabetic Nephropathy

导出

摘要目的:探讨百令胶囊联合依帕司他治疗早期糖尿病肾病的临床疗效。方法:68例2型糖尿病患者随机分为对照组及治疗组各34例,均给予基础治疗。同时对照组应用依帕司他胶囊150 mg·d^(-1),治疗组应用依帕司他胶囊150 mg·d^(-1)联合百令胶囊3.0g·d^(-1)治疗,疗程12周。观察两组24 h尿白蛋白含量、24 h尿微量白蛋白排泄率(UAER)、尿素氮(BUN)、血肌酐(SCr)、三酰甘油(TG)、总胆固醇(TC)、超敏C反应蛋白(hs-CRP)等指标的变化。结果:两组治疗后24 h尿白蛋白含量、24 h UAER均较治疗前降低(P<0.05),且治疗组24 h UAER下降较对照组更明显(P<0.05);治疗组治疗后SCr、TG、TC、hs-CRP等指标均较治疗前下降(P<0.05),且TG、TC、hs-CRP与对照组治疗后比较,差异有统计学意义(P<0.05)。结论:百令胶囊联合依帕司他治疗能有效降低早期糖尿病肾病患者24 h尿白蛋白含量、24 h UAER,调节血脂及改善慢性炎症。 Objective：To observe the effect of the combined therapy with Bailing capsules（BC） and epalrestat capsules in the treatment of early diabetic nephropathy.Method：Totally 68 patients with early diabetic nephropathy were randomly divided into the control group treated by epalrestat capsules（150 mg·d ^（-1）） and the treatment group treated by BC（3.0 g·d^（-1）） and epalrestat capsules （150 mg·d^（-1））,and the treatment course was 12 weeks.The changes in 24h urine albumin content,UAER,hihg-sensitine Creactive protein（hs-CRP） and blood lipids levels were measured to estimate the protective effect of the combined therapy.Result：After the 12-week treatment,the levels of 24h urine albumin content and UAER were decreased in the two groups with significant difference from those of pre-treatment（P 0.05）,and UAER was lower in the treatment group than that in the control group（P 0.05）. Meanwhile,the levels of SCr,blood triglyceride,total cholesterol and hs-CRP were decreased compared with those before the treatment （P 0.05 ）,and the levels of triglyceride,total cholesterol and hs-CRP in the treatment group were lower than those in the control group（P 0.05）.Conclusion：Combined use of BC and epalrestat capsules can significantly lower the 24h urine albumin content and UAER in the patients with early diabetic nephropathy to alleviate the renal impairment,regulate the blood lipids and improve the chronic inflammation.

作者李湘陈丹丹

机构地区湖南省第二人民医院代谢内分泌科

出处《中国药师》 CAS 2013年第3期413-415,共3页 China Pharmacist

关键词百令胶囊依帕司他尿白蛋白排泄率糖尿病肾病 Bailing capsules Epalreslat capsules Urine albumin excretion rate Diabetic nephropathy

分类号 R286 [医药卫生—中药学]

引文网络
相关文献

参考文献13

1Keane WF, Brenner BM, De Zeeuw D, et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropa- thy: the RENAAL study[J]. Kidney Int, 2003, 63(4) : 1499-1507.
2Walli AK, Grtine E, Miller B, et al. Role of lipoproteins in progres- sive renal disease[ J]. Am J Hypertens, 1993, 6 (11 ) : 358S-366S.
3World Health Organization. Definition, diagnosis and classifwation of diabetes mellitus[ R-. Geneva:WHO, 1999. 6 : 442-443.
4Mogensen CE, Chachati A, Christensen CK, et al. Microalbumin- uria: an early marker of renal involvement in diabetics [ J ]. Uremia Invest, 1985-1986, 9(2) : 85-95.
5Joss N, Paterson KR, Deighan C J, et al. Diabetic nephropathy: how effective is treatment in clinical practice [ J ]. Q J Med, 2002, 95 (1) : 41-49.
6Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to development of glucose disorders in the elderly : the Cardiovascular Health Study [ J ]. Diabetes, 2001, 50 (10) : 2384- 2389.
7Yamagishi S, Fukami K, Ueda S, et al. Molecular mechanisms of di- abetic nephropathy and its therapeutic intervention [ J ]. Curr Drug Targets, 2007, 8(8) : 952-959.
8Fornoni A, Ijaz A, Tejada T, et al. Role of inflammation in diabetic nephropathy[ J]. Curr Diabetels Rev, 2008, 4( 1 ) : 10-17.
9Lin J, Hu FB, Rimm EB, et al. The association of serum lipids and inflammatory biomarkers with renal function in men with type II dia- betes mellitus[J]. Kidney Int, 2006, 69(2): 336-342.
10Nishinaka T,Yabe-Nishimura C. EGF receptor-ERK pathway is the maior signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress[ J]. Free Radic Biol Med, 2001,31 (2) : 205-216.

二级参考文献28

1刘强,侯积寿,马济民,左静南,蒋更如,冯涵芳.虫草影响慢性肾功能衰竭进展的实验研究[J].中华肾脏病杂志,1995,11(2):81-82. 被引量：86
2郑丰,梁兰青,黎磊石,刘志红,周虹.冬虫夏草促进大鼠肾小管细胞增殖与其对庆大霉素急性肾损伤的防治作用[J].中国病理生理杂志,1995,11(2):211-215. 被引量：24
3胡绍文郭瑞林.实用糖尿病学[M].北京：人民军医出版社,1999.219-221.
4Zore I, Krasovec M, Cimerman N, et al. Cathepsin B cystatin C complex levels in sera from patients with lung and colorectal cancer [J]. Biol Chem,2001 ;382( 8 ) :805-10.
5Livak KJ,Sehmittgen TD. Analysis of relative gene expression data using real time quantitation PC R and the 2^ΔΔCt method [J]. Methods,2001 ;25 (4) :402-8.
6Chen S, Evans T, Deng D,et al. Hyperhexosemia induced functional and structural changes in the kidneys : role of endothelins [J]. Nephronology, 2002 ;90( 1 ) :86-94.
7陈慰峰.医学免疫学.北京:人民卫生出版社,2001,47.
8Kiho T, Yamane A, Hui J, et al. Pdysaccharides in fungi. ⅩⅩⅩⅥ. Hypoglycemic activity of a polysaccharide(CS- F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. Biol Pharm Bull, 1996, 19 (2) : 294 - 296.
9Kiho T, Ookubo K, Usui S, et al. Structural features and hypoglycemic activity of apolysaccharide (CS- F10 ) from the cultured mycelium of Cordyceps sinensis. Biol Pharm Bull, 1999,22 (9) :966 - 970.
10Romano M, Pomilio M, Vigneri S, et al. Endothelial Perturbation in children and adolescents with typel diabetes-association with markers of the inflammatory reaction. Diabetes Care, 2001,24 (9): 1674 - 1678.